Skip to content

Attenuating Glial Activation with Minocycline Reduces the Hyperthermic Response to 3, 4-Methylenedioxymethamphetamine (MDMA) In the Rat

Paul M Anderson

The Open Addiction Journal March 29, 2011 DOI: 10.2174/1874941001104010004 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Interventions Minocycline MDMA
Topics MDMA
Citations 3
Key findings Minocycline administration limited or prevented MDMA-induced hyperthermia, supporting the hypothesis that microglial activation plays a role in this response.

Abstract

Hyperthermia is a key clinical outcome from recreational use of MDMA and is the leading cause of MDMA related hospital admissions as well as being linked to enhanced neurotoxicity [1, 2]. Animal models of ischemia which also display hyperthermia have shown an inflammatory process mediated by microglia and the release of the proinflammatory cytokine interleukin 1(IL-1 ) play a role in hyperthermicreactions [3]. Previous studies showed that microglia is prominently activated and IL-1 levels increased following MDMA administration [4], lending support to the hypothesis microglia play a role in MDMA induced hyperthermia. Minocycline is a tetracycline antibiotic with powerful anti-inflammatory properties, thought to be a result of its ability to attenuate glial activation [5]. This study examined whether preventing microglial activation through the administration of minocycline could limit or prevent the hyperthermia induced by MDMA.

Comparable studies

Other experimental studies on MDMA, most cited first.

Citations in the library

Explore topics